MedPath

Clinical Characteristics and Outcome of Patients With COPD With Pneumonia

Completed
Conditions
Pneumonia
Chronic Obstructive Pulmonary Disease
Interventions
Other: No inervention
Registration Number
NCT04966026
Lead Sponsor
Peking University Third Hospital
Brief Summary

To identify the clinical characteristics of patients with chronic obstructive pulmonary disease (COPD) combined with community-acquired pneumonia (CAP) and the factors influencing clinical transition.

Detailed Description

To identify the clinical characteristics of patients with chronic obstructive pulmonary disease (COPD) combined with community-acquired pneumonia (CAP) and the factors influencing clinical transition.Compared to other chronic airway diseases, COPD patients can often have CAP in combination, but there is a lack of comparative studies between COPD patients with CAP and non-COPD patients with CAP.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
143
Inclusion Criteria
  1. CAP meets the diagnostic criteria published in 2016 Chinese CAP diagnosis and treatment guidelines; CPOPD and AECOPD meet the diagnostic criteria published in Chinese 2013 COPD diagnosis and treatment guidelines;
  2. Age ≧ 40years.
Read More
Exclusion Criteria
  1. age <40years;
  2. pregnancy;
  3. positive for human immunodeficiency virus (HIV) antibodies;
  4. suspected or confirmed tuberculosis or fungal infection of the lung.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
COPD combined with CAP inpatientsNo inervention(1) CAP meets the diagnostic criteria published in our 2016 CAP diagnosis and treatment guidelines; CPOPD and AECOPD meet the diagnostic criteria published in our 2013 COPD diagnosis and treatment guidelines; (2) age ≧ 18 years. Exclusion criteria: (1) age \<18 years; (2) pregnancy; (3) positive human immunodeficiency virus (HIV) antibody; (4) suspected or confirmed tuberculosis or fungal infection of the lung.
Primary Outcome Measures
NameTimeMethod
mortality rateDay 28 from hospitalization

mortality rate

Secondary Outcome Measures
NameTimeMethod
number of days in ICUthrough study completion, an average of 1 year

number of days in ICU

hospital feesthrough study completion, an average of 1 year

hospital fees.

cause of using antimicrobial drugsthrough study completion, an average of 1 year

Days of using antimicrobial drugs during hospitalization

Number of days in hospitalthrough study completion, an average of 1 year

Number of days in hospital

number of days on mechanical ventilationthrough study completion, an average of 1 year

number of days on mechanical ventilation

Trial Locations

Locations (1)

Peking University Third Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath